340B Drug Pricing Program: Obama Administration Issues Much Awaited Final Rule

• By: Staff Editor
• Date: January 11, 2017
• Source: http://www.raps.org

340B Drug Pricing Program: Obama Administration Issues Much Awaited Final Rule

The Health Resources and Services Administration (HRSA) within HHS has lately issued a final rule that imposes civil monetary penalties on drug manufacturers for overcharging hospitals and clinics covered under 340B drug discount program. The HHS initially proposed the rule in June 2015, opened for comment and then extended the comment period.